| Primary |
| Product Used For Unknown Indication |
100.0% |
|
|
| Secondary |
| Schizophrenia |
17.9% |
| Asperger's Disorder |
17.6% |
| Depression |
12.3% |
| Product Used For Unknown Indication |
11.8% |
| Analgesic Therapy |
6.0% |
| Sedation |
6.0% |
| Extrapyramidal Disorder |
4.6% |
| Muscle Spasms |
3.9% |
| Psychotic Disorder |
3.1% |
| Neck Pain |
2.9% |
| Dyspepsia |
2.4% |
| Oculogyric Crisis |
2.2% |
| Depressed Mood |
1.9% |
| Post-traumatic Stress Disorder |
1.9% |
| Salivary Hypersecretion |
1.9% |
| Hiv Infection |
1.2% |
| Hypomania |
0.7% |
| Constipation |
0.5% |
| Diarrhoea |
0.5% |
| Myalgia |
0.5% |
|
| Weight Increased |
34.1% |
| Vomiting |
14.6% |
| Serotonin Syndrome |
12.2% |
| White Blood Cell Count Decreased |
9.8% |
| Platelet Count Decreased |
4.9% |
| Sleep Apnoea Syndrome |
4.9% |
| Full Blood Count Abnormal |
2.4% |
| Pulmonary Embolism |
2.4% |
| Sleep Disorder |
2.4% |
| Tardive Dyskinesia |
2.4% |
| Toxicity To Various Agents |
2.4% |
| Tremor |
2.4% |
| Unevaluable Event |
2.4% |
| White Blood Cell Count Increased |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.1% |
| Schizophrenia |
22.7% |
| Extrapyramidal Disorder |
5.8% |
| Depression |
5.0% |
| Gastric Cancer |
4.8% |
| Vomiting |
4.7% |
| Psychotic Disorder |
3.7% |
| Anxiety |
3.1% |
| Constipation |
2.3% |
| Insomnia |
1.9% |
| Mental Disorder |
1.6% |
| Abnormal Behaviour |
1.4% |
| Depressed Mood |
1.4% |
| Mania |
1.4% |
| Salivary Hypersecretion |
1.4% |
| Diabetes Mellitus |
1.2% |
| Pain |
1.2% |
| Epilepsy |
1.1% |
| Parkinsonism |
1.1% |
| Suicidal Behaviour |
1.1% |
|
| White Blood Cell Count Increased |
31.0% |
| Toxicity To Various Agents |
13.3% |
| Rhabdomyolysis |
8.8% |
| Unresponsive To Stimuli |
5.3% |
| Sedation |
4.4% |
| Vomiting |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Neutropenia |
3.5% |
| Liver Function Test Abnormal |
2.7% |
| Prothrombin Time Shortened |
2.7% |
| Rectal Haemorrhage |
2.7% |
| Vasculitic Rash |
2.7% |
| Convulsion |
1.8% |
| Grand Mal Convulsion |
1.8% |
| Iron Deficiency Anaemia |
1.8% |
| Rash |
1.8% |
| Renal Failure Acute |
1.8% |
| Renal Impairment |
1.8% |
| Renal Injury |
1.8% |
| Urinary Tract Infection |
1.8% |
|
| Interacting |
| Analgesic Therapy |
11.8% |
| Depression |
11.8% |
| Muscle Spasms |
11.8% |
| Product Used For Unknown Indication |
11.8% |
| Schizophrenia, Paranoid Type |
11.8% |
| Sedation |
11.8% |
| Dyspepsia |
5.9% |
| Extrapyramidal Disorder |
5.9% |
| Neck Pain |
5.9% |
| Post-traumatic Stress Disorder |
5.9% |
| Psychotic Disorder |
5.9% |
|
| Visual Impairment |
75.0% |
| White Blood Cell Count Decreased |
25.0% |
|